Ultragenyx Pharmaceutical - 株価


価格 日 年
Kyowa Hakko Kirin 2,958.00 -77.00 -2.54% 13.55%
Acadia Pharmaceuticals 47.31 -1.38 -2.83% 17.63%
Agios Pharmaceuticals 50.29 -2.60 -4.92% 3.97%
Alnylam Pharmaceuticals 146.59 -5.00 -3.30% 24.18%
Alexion Pharmaceuticals 153.65 -0.84 -0.54% 62.11%
Aptinyx Inc 3.61 -0.19 -5.00% 15.71%
BioCryst Pharmaceuticals 10.47 -1.34 -11.35% 313.83%
Bluebird Bio 28.12 2.20 8.49% -61.32%
BioMarin Pharmaceutical 81.76 -1.56 -1.87% -10.37%
Epizyme 9.66 -0.53 -5.20% -55.36%
Esperion Therapeutics 27.68 -0.87 -3.05% -51.48%
GW Pharmaceuticals 214.85 -0.15 -0.07% 100.79%
Insmed 37.16 -2.87 -7.17% 41.19%
Ionis Pharmaceuticals 53.41 -2.80 -4.98% -4.54%
Karyopharm Therapeutics 14.56 -0.24 -1.62% 1.25%
MacroGenics 21.88 0.81 3.84% 82.18%
Moderna Inc 148.67 3.88 2.68% 409.84%
Mirati Therapeutics 195.60 -7.30 -3.60% 120.59%
Neurocrine Biosciences 106.81 -3.80 -3.44% 13.69%
Puma Biotechnology 10.55 -0.76 -6.72% -0.57%
PTC Therapeutics 55.19 -2.44 -4.23% 1.56%
Ultragenyx Pharmaceutical 136.25 -6.48 -4.54% 144.57%
Regeneron Pharmaceuticals 453.19 -5.41 -1.18% -1.03%
Sarepta Therapeutics 85.25 0.96 1.14% -24.98%
Vertex Pharmaceuticals 212.98 -4.06 -1.87% -8.21%
Immunic Inc. 15.64 -0.74 -4.52% 74.94%
Acceleron Pharma 135.87 -0.91 -0.67% 55.53%
Xoma 36.20 -0.92 -2.48% 49.16%

価格 日 年
NASDAQ 13119 -478.54 -3.52% 46.08%
Russell 2000 2200 -84.21 -3.69% 41.69%

RARE:US
資産
現金と同等
売上原価
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
売上総利益
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者